Medicus Pharma Ltd. (MDCX)

Medicus Pharma Statistics

Total Valuation

Medicus Pharma has a market cap or net worth of $16.11 million. The enterprise value is $12.28 million.

Market Cap	16.11M
Enterprise Value	12.28M

Important Dates

The last earnings date was Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Medicus Pharma has 55.16 million shares outstanding. The number of shares has increased by 102.71% in one year.

Current Share Class	55.16M
Shares Outstanding	55.16M
Shares Change (YoY)	+102.71%
Shares Change (QoQ)	+58.81%
Owned by Insiders (%)	6.17%
Owned by Institutions (%)	5.66%
Float	48.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.81
P/TBV Ratio	12.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.22, with a Debt / Equity ratio of 1.77.

Current Ratio	1.22
Quick Ratio	1.07
Debt / Equity	1.77
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-50.89

Financial Efficiency

Return on equity (ROE) is -2,865.18% and return on invested capital (ROIC) is -568.20%.

Return on Equity (ROE)	-2,865.18%
Return on Assets (ROA)	-278.12%
Return on Invested Capital (ROIC)	-568.20%
Return on Capital Employed (ROCE)	-1,976.28%
Weighted Average Cost of Capital (WACC)	1.75%
Revenue Per Employee	n/a
Profits Per Employee	-$3.20M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.99% in the last 52 weeks. The beta is -0.91, so Medicus Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.91
52-Week Price Change	-95.99%
50-Day Moving Average	0.37
200-Day Moving Average	1.48
Relative Strength Index (RSI)	40.73
Average Volume (20 Days)	1,876,611

Short Selling Information

The latest short interest is 1.76 million, so 3.19% of the outstanding shares have been sold short.

Short Interest	1.76M
Short Previous Month	1.99M
Short % of Shares Out	3.19%
Short % of Float	3.61%
Short Ratio (days to cover)	0.27

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.11M
Pretax Income	-51.22M
Net Income	-51.22M
EBITDA	n/a
EBIT	-29.11M
Earnings Per Share (EPS)	-$2.37

Balance Sheet

The company has $6.37 million in cash and $2.53 million in debt, with a net cash position of $3.83 million or $0.07 per share.

Cash & Cash Equivalents	6.37M
Total Debt	2.53M
Net Cash	3.83M
Net Cash Per Share	$0.07
Equity (Book Value)	1.43M
Book Value Per Share	0.03
Working Capital	1.33M

Cash Flow

Operating Cash Flow	-27.81M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	1.29M
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medicus Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.71%
Shareholder Yield	-102.71%
Earnings Yield	-317.99%
FCF Yield	n/a

Analyst Forecast

The average price target for Medicus Pharma is $6.50, which is 2,126.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.50
Price Target Difference	2,126.03%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 25, 2024. It was a reverse split with a ratio of 1:2.

Last Split Date	Oct 25, 2024
Split Type	Reverse
Split Ratio	1:2

Scores

Altman Z-Score	n/a
Piotroski F-Score	1